Xenikos

0 followers


Xenikos is developing a combination of two toxin-loaded anti-T-cell antibodies.

Industries

+1

Stage

Employees

Links

Org chart

André de Lege
Controller & Accountant
Maria Marza Perez
CMC Project Manager
Jürgen van de Lagemaat
Director, Process Development & Commercialization